FRANK
R. LICHTENBERG
Curriculum
Vitae
September
2009
|
Columbia University Graduate School of Business 504 Uris Hall 3022 Broadway New York, NY 10027 |
Phone: (212) 854-4408 Fax: (212) 854-9895 Home office phone: (914) 882-7143 e-mail: frank.lichtenberg@columbia.edu
|
CURRENT POSITIONS
Courtney C. Brown Professor of Business,
Columbia University Graduate School of Business
Visiting Professor, Victoria University,
Melbourne, Australia
Research Associate, National Bureau of
Economic Research
Productivity
and Health Care Programs
Research Fellow, CESifo (Center for Economic
Studies/Ifo Institute for Economic Research)
Associate Editor, Management Science
Associate Editor, Economics
Editorial Board member, Journal of Evolutionary Economics
Editorial Board member, Defence and Peace Economics
Member, Conference on Research in Income and
Wealth
Affiliate, LECG, LLC (economic consulting
services firm)
Advisory Board, Center for Medical Progress,
Manhattan Institute for Policy Research
AWARDS
Winner of the 2003 Milken Institute Award for
Distinguished Economic Research for the paper, Pharmaceutical
Knowledge-Capital Accumulation and Longevity.
Winner of the 1998 Schumpeter Prize for the
paper, Pharmaceutical Innovation as a
Process of
Creative
Destruction.
Margaret Chandler Memorial Award for
Commitment to Excellence ("Best Teacher Award") by the Columbia
Business School Executive MBA Class of 1994-II.
EDUCATION
Ph.D. Economics, University of Pennsylvania,
1982
Dissertation:
Training, Tenure, and Productivity
Graduate Honors received: University Fellow, Teaching Fellow, Graduate
Group Fellow
M.A. Economics, University of Pennsylvania,
1976
B.A. with Honors, History, University of
Chicago, 1973
National Merit Scholar Finalist, 1969
attended University of Warwick (England), Fall 1972
PREVIOUS TEACHING AND RESEARCH POSITIONS
Member, Advisory Committee, Division of
Information Management, New York Academy of Medicine
Visiting Scholar, Federal Trade Commission,
Fall 1997
Visiting Scholar, Center for Economic
Studies, University of Munich, July 1997
Columbia University Graduate School of
Business
Head
of Economics Group, 1994-96
Professor,
1992-95
Associate
Professor, 1986-92
Assistant
Professor, 1983-86
Visiting Scholar, Wissenschaftszentrum
Berlin, July 1995
Visiting Scholar, Kiel (Germany) Institute of
World Economics, August 1993
National Bureau of Economic Research
Faculty
Research Fellow, 1982-86
Research
Economist, 1980-82
Jerome Levy Economics Institute at Bard
College
Research
Fellow, 1989-90
American Statistical Association/National
Science Foundation/Census Bureau
Research
Fellow, 1986-87
Columbia University, Center for Education and
the American Economy
Senior
Research Associate, 1985-87
University of Adelaide (Australia)
Visiting
Lecturer, 1982
Harvard University
Instructor,
1982
U.S. Bureau of Labor Statistics, Office of
Economic Growth
Dissertation
Fellow, 1979-80
Brookings Institution
Research
Fellow in Economics, 1978-79
University of Pennsylvania, Wharton School
Instructor,
1978
U.S. Congressional Budget Office, Budget
Analysis Division
Intern,
1977
U.S. Department of Justice, Antitrust
Division
Intern,
1976
Henry Dreyfuss Associates (Industrial
Designers), Production Manager, 1973-75
PUBLICATIONS
Book
Corporate
Takeovers and Productivity
(Cambridge: MIT Press, 1992).
Articles
“The effect of drug vintage on survival: micro
evidence from Puerto Rico’s Medicaid program,” http://www.nber.org/papers/w10884,
Advances in Health Economics Health
Services Research 22, forthcoming http://www.sciencedirect.com/science/journal/07312199
“The impact
of drug vintage on patient survival: a patient-level analysis using Quebec’s provincial
health plan data,” with Paul Grootendorst, Marc Van Audenrode, Dominick Latremouille-Viau, and
Patrick Lefebvre, Value in Health,
forthcoming.
“International
differences in cancer survival rates: the role of new drug launches,” International
Journal of Healthcare Technology and Management 10 (3), 138-55.
“Does Misery Love Company? Evidence from pharmaceutical markets before
and after the Orphan Drug Act,” with Joel Waldfogel, Michigan Telecommunications and Technology Law Review, forthcoming.
“The effect of new cancer drug approvals on
the life expectancy of American cancer patients, 1978-2004,” Economics of Innovation and New Technology
18 (5), 407-28.
“Home, or nursing home? The effect of medical innovation on the
demand for long-term care,” in J. Costa i Font, A. McGuire and C. Courbage
(eds), The Economics of New Health Technologies: Incentives, Organisation
and Financing, Oxford University Press.
“Have
newer cardiovascular drugs reduced hospitalization? Evidence from longitudinal country-level data
on 20 OECD countries, 1995-2003,” Health
Economics, http://www3.interscience.wiley.com/journal/120750818/abstract
“Pharmaceutical
innovation and the longevity of Australians: a first look,” with Gautier
Duflos, Advances in Health Economics and
Health Services Research 19, 2008, pp 95-117.
"Pharmaceutical Innovation and U.S.
Cancer Survival, 1992-2003: Evidence from Linked SEER-MEDSTAT Data," Forum
for Health Economics & Policy: Vol. 10: Iss. 1 (Frontiers in Health
Policy Research), Article 1. http://www.bepress.com/fhep/10/1/1
“The Effect Of
Education On Medical Technology Adoption: Are The More Educated More Likely To
Use New Drugs?,” with Adriana Lleras-Muney, Annales d’Economie et de Statistique, forthcoming.
“The impact of Medicare Part D
on prescription drug use by the elderly: evidence from a large retail pharmacy
chain,” with Shawn Sun, Health Affairs
26(6), November/December 2007, 1735-44.
“Importation and
innovation,” Economics of Innovation and
New Technology, 2007, Vol.
16(6), September, pp. 403–417
“Benefits and Costs of Newer Drugs: An
Update,” Managerial and Decision
Economics 28: 485–490 (2007).
“Pharmaceutical-embodied technical progress,
longevity, and quality of life: drugs as ‘equipment for your health,’” with
Suchin Virabhak, Managerial and Decision
Economics 28: 371–392
(2007)
“The Effect of Drug Vintage on
Mortality: Economic Effect of New Drugs,” with Kee Taig Jung and Jeong Yoon
Kim, Korean Journal of Health Policy and
Administration 16(4),
December 2006, 147-68.
“Effects of new
drugs on overall health spending: Frank Lichtenberg responds,” Health Affairs 26(3), May-June, 887-90.
“The effect of using
newer drugs on admissions of elderly Americans to hospitals and nursing homes:
state-level evidence from 1997-2003,” Pharmacoeconomics
24 Suppl 3, 2006, 5-25.
“The Impact of New Drugs on U.S. Longevity and
Medical Expenditure, 1990-2003,”American
Economic Review 97 (2), May 2007, 438-443.
“The impact of increased
utilization of HIV drugs on longevity and medical expenditure: an assessment
based on aggregate U.S. time-series data,” Expert
Review of Pharmacoeconomics and Outcomes Research, Volume 6, Number 4,
August 2006, 425-436.
“Did CMS’ Functional
Equivalence Decision Result in Equitable Payments?,” Journal of Pharmaceutical Finance, Economics & Policy 15(1),
2006, 7-20.
“Has using newer drugs reduced
admissions to hospitals and nursing homes?,” Swiss Journal of Economics and Statistics 142, 2006, pp. 69-75.
“The Benefits to Society of New Drugs: A Survey of the Econometric
Evidence,” in Engaging the New World: Responses
to the Knowledge Economy, edited by Bhajan S. Grewal and Margarita Kumnick, Melbourne
University Press, Melbourne, 2006.
“Pharmaceutical
Innovation as a Process of Creative Destruction,” in Knowledge Accumulation and Industry Evolution: The Case of
Pharma-Biotech, ed. by Mariana Mazzucato and Giovanni Dosi (Cambridge
University Press, 2006), pp. 21-72.
"Pharmaceutical innovation and the burden of
disease in developing and developed countries," Journal of Medicine and
Philosophy 30(6), December
2005.
“Pharmaceutical
Knowledge-Capital Accumulation and Longevity,” in Measuring Capital in the New Economy, ed. by Carol Corrado, John
Haltiwanger, and Dan Sichel, pp. 237-269 (University of Chicago Press, 2005).
"Availability
of new drugs and Americans' ability to work," Journal of Occupational and Environmental Medicine 47 (4), April 2005,
373-380.
“The Effect of Access Restrictions on the
Vintage of Drugs Used by Medicaid Enrollees,” American Journal of Managed Care 11, Special Issue, 2005, SP7-SP13.
"The impact of
new drug launches on longevity: evidence from longitudinal disease-level data
from 52 countries, 1982-2001," International
Journal of Health Care Finance and Economics 5, 2005, pp. 47-73.
“Sources of U.S. Longevity Increase,
1960-2001,” Quarterly Review of Economics and Finance 44(3),
pp.
369-389 (July 2004).
“Public
policy and innovation in the U.S. pharmaceutical industry,” in Public Policy and the Economics of
Entrepreneurship, ed. by Douglas Holtz-Eakin and Harvey S. Rosen (MIT
Press, 2004), pp. 83-113.
“The Effect of New
Drugs on HIV Mortality in the U.S., 1987-1998,” Economics and Human Biology 1 (2003) 259-266.
“Pharmaceutical
Innovation, Mortality Reduction, and Economic Growth,” in Measuring the Gains from Medical Research: An Economic Approach,
ed. by Kevin M. Murphy and Robert H. Topel (Chicago: University of Chicago
Press, 2003), pp. 74-109.
“The Dual Effects of
Intellectual Property Regulations: Within- and Between-Patent Competition in
The US Pharmaceuticals Industry,” with Tomas Philipson, Journal of Law &
Economics 45, pp. 643-672, 2002.
“The Effects of
Medicare on Health Care Utilization and Outcomes,” Frontiers in Health Policy Research, Vol. 5, ed. by Alan Garber
(MIT Press, 2002).
“Are the Benefits of
Newer Drugs Worth Their Cost? Evidence from the 1996 MEPS,” Health Affairs 20(5), September/October
2001, 241-51.
“Does foreign direct
investment transfer technology across borders?,” with Bruno van Pottelsberghe de la Potterie, The
Review of Economics and Statistics, Aug 2001; Vol. 83, Iss.
3; pp. 490-7.
“The Allocation of
Publicly Funded Biomedical Research,” in Medical
Care Output and Productivity, Studies in Income and Wealth Volume 62, ed.
by Ernst Berndt and David Cutler (University of Chicago Press, 2001), 565-89.
“The Effect of Pharmaceutical Utilisation and
Innovation on Hospitalisation and Mortality,” in Productivity, Technology, and Economic Growth, ed. by B. van Ark,
S. K. Kuipers and G. Kuper (Kluwer Academic Publishers, 2000).
"The European Strategic Programme for
Research in Information Technologies (ESPRIT): An Ex-Post Analysis," in The Political Economy of Industrial Policy,
ed. by D. Neven and Lars-Hendrik Roller (Wissenschaftszentrum Berlin and
Edition Sigma).
“Managerial Ownership
and Firm Performance: A Re-examination Using Productivity Measurement,” with
Darius Palia, Journal of Corporate
Finance: Contracting, Governance and Organization 5(4), December 1999,
323-39.
“Information Technology
and Its Impact on Productivity: Firm-level Evidence from Government and Private
Data Sources, 1977-1993,” with
Bill Lehr, Canadian Journal of Economics
32(2), April 1999, 335-62.
"Computer Use and Productivity Growth in
Federal Government Agencies, 1987-92," with Bill Lehr, Journal of Industrial Economics 46(2),
June 1998, 257-79.
“International R&D
Spillovers: A Comment,” with Bruno van Pottelsberghe de la Potterie, European
Economic Review 42(8), September 1998, 1483-91.
“The Impact and Organization of
Publicly-Funded Research and Development in the European Community,” with
Maryann Feldman, Annales d’Economie et
Statistique 0(49-50), (in English), Jan.-June 1998, 199-222.
“Technology Investment is Driving Economic
Growth,” in The Rising Tide, ed. by
Jerry Jasinowski (New York: Wiley, 1998), 163-9.
“Commentary: Shoring up Government Support,” in
The Future of Biomedical Research,
ed. by Claude Barfield and Bruce Smith (Washington: American Enterprise
Institute and Brookings Institution, 1997), 67-72.
"Do (More and Better) Drugs Keep People
Out of Hospitals?," American
Economic Review 86, May, 1996, 384-8.
"Labour Market Institutions, Liquidity
Constraints, and Macroeconomic Stability," Journal of Economic Behavior and Organization 28 (1995), 145-54.
"The Output Contributions of Computer
Equipment and Personnel: A Firm-Level Analysis," Economics of Innovation and New Technology 3 (1995), 201-17.
“The Economics of Defense R&D," in The Handbook of Defense Economics,
Volume 1, ed. by K. Hartley and T. Sandler. Handbooks in Economics, vol. 12.
(Amsterdam, New York and Oxford: Elsevier, 1995), 431-57.
"Ownership Structure and Corporate
Performance in Japan," with George Pushner, Japan and the World Economy 6 (1994), 239-61.
"Testing the Convergence
Hypothesis," Review of Economics and
Statistics 76(3), August 1994, 576-9.
"An Industry-Level Analysis of Import
Relief Petitions Filed by U.S. Manufacturers, 1958-1985," with Hong Tan,
in Troubled Industries in the United
States and Japan, ed. by Hong Tan and Haruo Shimada (New York: St. Martin's
Press, 1994), 161-88.
"Have International Differences in Educational
Attainment Levels Narrowed?," in Convergence
of Productivity: Cross-National Studies and Historical Evidence, ed. by W.
Baumol, R. Nelson, and E. Wolff (New York: Oxford University Press, 1994),
225-42.
"R&D Investment and International
Productivity Differences," in Economic
Growth in the World Economy, ed. by Horst Siebert (Tubingen: J. C. B. Mohr,
1993), 89-110.
"Industrial De-Diversification and Its
Consequences for Productivity," Journal
of Economic Behavior and Organization 18 (1992), 427-38.
"A Perspective on Accounting for Defense
Contracts," The Accounting Review
67 (4), 742-53, October 1992.
"Asset Stripping," in The New Palgrave Dictionary of Money and
Finance, J. Eatwell, M. Milgate, and P. Newman, eds. (London: Macmillan,
1992).
"The Managerial Response to Regulation
of Financial Reporting for Segments of a Business Enterprise," Journal of Regulatory Economics 3
(1991), 241-9.
"The Age of Technology and Its Impact on
Employee Wages," with Ann Bartel, Economics
of Innovation and New Technology 1 (1991), 215-31.
"The Impact of R&D Investment on
Productivity: New Evidence Using Linked R&D-LRD Data," with Donald
Siegel, Economic Inquiry 29 (1991),
April, 203-28.
"The Effect of Leveraged Buyouts on
Productivity and Related Aspects of Firm Behavior," with Donald Siegel, Journal of Financial Economics 26
(1990), 165-94.
"The Effect of Ownership Changes on the
Employment and Wages of Central-Office and Other Personnel," with Donald
Siegel, Journal of Law and Economics
33 (1990), October, 383-408.
"U.S. Government Subsidies to Private
Military R&D: The Defense Department's Independent R&D Policy," Defense Economics 1 (1990), 149-58.
"Aggregation of Variables in
Least-Squares Regression," American
Statistician 44 (1990), 169-71.
"Issues in Measuring Industrial
R&D," Research Policy 19
(1990), 157-63.
"How Elastic is the Government's Demand
for Weapons?," Journal of Public
Economics 40 (1989), 57-78.
"The Effect of Control Changes on the
Productivity of U.S. Manufacturing Plants," with Donald Siegel, Journal of Applied Corporate Finance,
August 1989, 60-7.
"Contributions to Federal Election
Campaigns by Government Contractors," Journal
of Industrial Economics 38, September 1989, 31-48.
"IR&D Project Data and Theories of
R&D Investment," Journal of
Economic Dynamics and Control 13, 1989, 271-82.
"Errors of Measurement in Output
Deflators," with Zvi Griliches, Journal
of Business and Economic Statistics 7, Jan. 1989, 1-9.
"The Impact of the Strategic Defense
Initiative on U.S. Civilian R&D Investment and International
Competitiveness," Social Studies of
Science 19(2), 1989; also published (in French) in J.J. Salomon (ed.), Science, Guerre et Paix (Paris:
Economica, 1989), 137-56.
"Managerial Economics," in The Portable MBA, Mary Anne Devanna and
Eliza G.C. Collins, eds. (New York: Wiley, 1989).
"Estimation of the Internal Adjustment
Costs Model Using Longitudinal Establishment Data," Review of Economics and Statistics 70(3), August 1988, 421-30.
"The Private R&D Investment Response
to Federal Design and Technical Competitions," American Economic Review 78(3), June 1988, 550-9.
"Productivity Improvements from Changes
in Ownership," Mergers and
Acquisitions 23(2), Sept./Oct. 1988, 48-50.
"Assessing the Impact of Federal
Industrial R&D Expenditure on Private R&D Activity in the U.S.,"
in The Relation Between Defence and Civil
Technologies, Philip Gummett and Judith Reppy, eds. (Dordrecht: Kluwer
Academic Publishers, 1988), 68-87.
"Productivity and Changes in Ownership
of Manufacturing Plants," with Donald Siegel, Brookings Papers on Economic Activity, 1987:3, 643-73.
"The Effect of Government Funding on
Private Industrial Research and Development: A Re-Assessment," Journal of Industrial Economics 36(1),
Sept. 1987.
"Changing Market Opportunities and the
Structure of R&D Investment: The Case of Energy," Energy Economics 9(3), July 1987, 154-8.
"The Comparative Advantage of Educated
Workers in Implementing New Technology," with Ann Bartel, Review of Economics and Statistics
69(1), Feb. 1987, 1-11.
"The Skill Distribution and Competitive
Trade Advantage of High-Technology Industries," with Ann Bartel, in Advances in Industrial and Labor Relations,
Vol. 4, D. Lewin, D. Lipsky, and D. Sockell, eds. (JAI Press, 1987).
"The Duration and Intensity of
Investment in Independent Research and Development Projects," Journal of Economic and Social Measurement
14, 1986, 207-18.
"Energy Prices and Induced
Innovation," Research Policy 15,
1986, 67-75.
"Interindustry Technology Flows and
Productivity Growth: A Re-Examination," with Zvi Griliches, Review of Economics and Statistics
66(2), May 1984.
"The Relationship Between Federal
Contract R&D and Company R&D," American
Economic Association Papers and Proceedings 74(2), May 1984.
"R&D and
Productivity at the Industry Level: Is There Still a Relationship?," with
Zvi Griliches, in R&D, Patents, and
Productivity, Zvi Griliches, ed. (Chicago: Univ. of Chicago Press, 1984),
pp. 465-496.
“Commentary on
‘Methuselah's Medicine: Pharmaceutical Innovation and Mortality in the United
States, 1960 to 2000’,” Social Science and Medicine, forthcoming.
“Letter to the Editor,” Journal of General
Internal Medicine, forthcoming.
Comment on
“M&As in the USA: Lessons from the last 100 years,” by John Matsusaka, in Institutional and Policy Reforms to Enhance
Corporate Efficiency in Korea, ed. by Lee-Jay Cho, Somi Seong, and
Sang-Hyop Lee (Seoul: Korea Development Institute, 2007), pp. 231-235.
“Yes, New Drugs
Save Lives,” Washington Post, July 11, 2007; A15.
“Clinical Laboratory Innovation Means Better
Health, Longer Lives,” Laboratory Medicine 36 (8), p. 452+,
August 2005.
“Cover These Treatments ,”
Washington Post (op-ed article),
August 20, 2004, page A19 (also appeared in Houston
Chronicle).
“Longer Living Through Chemistry,” The
Milken Institute Review 6 (1), First Quarter 2004, 16-26.
“The Value of New Drugs,” The
Milken Institute Review 6 (1), Fourth Quarter 2003, 17-25.
“The Economic and Human Impact
of New Drugs,” Journal of Clinical
Psychiatry 64, Supplement 17, 2003, 15-18.
“The Benefits to Society of New Drugs: A Survey of the Econometric
Evidence,” in Science & Cents:
Exploring the Economics of Biotechnology, ed. By John Duca and Mine Yucel
(Dallas: Federal Reserve Bank of Dallas, 2003), 43-59.
“Probing the Link Between Gross Profitability and R&D Spending,” Health Affairs 20(5), September/October
2001, 221-2.
Comment on Papers by Frank and Salkever and
by Skinner and Wennberg, in The Changing
Hospital Industry: Comparing Not-for-Profit and For-Profit Institutions,
edited by David M. Cutler, The University of Chicago Press, 2000
Comment on Paper by Barro and Cutler, in Mergers and Productivity, edited by
Steven N. Kaplan, The University of Chicago Press, 2000
Comment on Paper by McGuckin, Nguyen, and Reznek, in Labor Statistics Measurement Issues
edited by John Haltiwanger, Marilyn E. Manser, and Robert Topel, The University
of Chicago Press, 1998.
“Do (more and better) medicines keep people
out of hospitals?” (Pfizer Forum), The
Economist, October 26, 1996, p. 63.
Review of The Performance of Companies, by Stephen
Nickell (Oxford, U.K.: Blackwell, 1995), in The
Journal of Economics.
Comment on “Efficiency in manufacturing and
the need for global competition,” by Martin Baily and Neil Gersbach, Brookings Papers on Economic Activity:
Microeconomics 1995.
"Rejoinder to Comment by Maarten
Vendrik," Journal of Economic
Behavior and Organization 28, Dec. 1995. p. 455.
Comment on " Productivity levels in
Germany, Japan, and the United States: Differences and causes," by Bart
van Ark and Dirk Pilat, Brookings Papers
on Economic Activity: Microeconomics 1993.
"Another Way to Measure IT's
Productivity Contribution," The
Brookings Review 12, Fall 1994, 2.
Review of International
High-Technology Competition, by F. M. Scherer, in The Journal of Economic Literature XXXI (4), Dec. 1993, 2015-7.
Comment on "Decade of Debt: Lessons from
LBOs in the 1980s," by William Long and David Ravenscraft, in The Deal Decade: What Takeovers and
Leveraged Buyouts Mean for Corporate Governance, edited by Margaret Blair
(Washington: Brookings, 1993), 230-234.
"In a Downturn, Cut Profits Before
Jobs" New York Times (Sunday
Business Section), Feb. 16, 1992, Section 3, p. 13.
"Want More Productivity? Kill That Conglomerate,"
Wall Street Journal (editorial page
article), Jan. 16, 1990.
"The Issues in Restructuring," Institutional Investor, June 1989.
"In Takeover Wars, Everyone
Wins," New York Times (Business Forum article), June 18, 1989.
"Takeovers Slash Corporate
Overhead," Wall Street Journal
(editorial page article), Feb. 7, 1989.
"What Makes Plant Productivity
Grow?," Wall Street Journal
(editorial page article), Dec. 24, 1987; also published (in Italian) in Il Sole 24 Ore (Milan), Jan. 20, 1988.
Review of The
Burden of Government, by Edwin S. Mills (Stanford: Hoover Institution
Press, 1986) in Journal of Comparative
Economics 12(2), June 1988, 304-5.
"Military R&D Depletes Economic
Might," Wall Street Journal
(editorial page article), Aug. 21, 1986; reprinted in Impact, newsletter of the Institute of Electrical and Electronic
Engineers 11(1), May 1987.
CONGRESSIONAL TESTIMONY
Testified before the House Committee on
Science, Space, and Technology in hearings on "Corporate Restructuring and
Its Effects on R&D," July 13, 1989.
SOURCES OF RESEARCH GRANTS, FELLOWSHIPS, AND
CONTRACTS
|
American Assembly of Collegiate Schools of
Business |
Merck and Co. |
|
American Enterprise Institute |
National Institute of Education |
|
American Statistical Association |
National Institutes of Health |
|
Federal Trade Commission |
National Pharmaceutical Council |
|
French-American Foundation |
National Science Foundation |
|
Fulbright Commission |
Pfizer, Inc. |
|
German Academic Exchange Service |
RAND Corporation |
|
German Marshall Fund of the U.S. |
Research Triangle Institute |
|
Jerome Levy Economics Institute |
Securities Industry Association |
|
MacArthur Foundation |
Alfred P. Sloan Foundation |
|
|
U.S. Bureau of the Census |
CONSULTING AND REVIEWING ACTIVITIES
Reviewer
for:
|
Administrative Science Quarterly |
Journal of Industrial Economics |
|
American Economic Review |
Journal of Labor Economics |
|
Commonwealth Fund |
Journal of Peace Research
|
|
Econometrica |
Journal of Political Economy |
|
Economic Letters |
Journal of Policy Analysis and Management |
|
Economica |
Journal of Productivity Analysis |
|
Economics of Innovation and New Technology |
Journal of Public Economics |
|
European Economic Review |
Journal of the American Medical Association |
|
Financial Management |
Medical Care |
|
Health Affairs |
MIT Press
|
|
Health Economics |
National Science Foundation |
|
Industrial Relations |
Oxford University Press |
|
International Journal of Epidemiology |
Population Studies |
|
International Journal of Industrial
Organization |
Prentice Hall |
|
Journal of Comparative Economics |
Princeton University Press |
|
Journal of Development Economics |
Quarterly Journal of Economics |
|
Journal of Economic Behavior and
Organization |
Rand Journal of Economics |
|
Journal of Econometrics |
Research Policy |
|
Journal of Economic Literature |
Review of Income and Wealth |
|
Journal
of Health
Economics |
Science
|
|
Journal
of Health
Politics, Policy and Law |
University of Chicago Press |
Consultant
to:
|
Amer. Fed. of State, County, and Municipal
Employees |
New York City Water Board |
|
American Hospital Association |
New York State Dept. of Econ. Devel. |
|
American Society for Clinical Oncology |
OECD |
|
Barr Laboratories |
Pennie and Edmonds |
|
Community Preservation Corporation |
RAND Corporation |
|
Consortium on Productivity in the Schools |
Research Triangle Institute |
|
Economic Policy Institute/Union of
Concerned Scientists |
Skadden, Arps, Slate, Meagher, & Flom |
|
Gellman Research Associates |
Touche, Ross, and Co. |
|
Institute of Medicine |
U.S. Bureau of the Census |
|
Internal Revenue Service |
Wachtell, Lipton, Rosen & Katz |
|
National Institute of Standards &
Technology |
Weil, Gotshal, & Manges |
|
National Science Foundation |
World Health Organization |
|
New York Attorney General |
|